{"database": "lobbying", "table": "lobbying_activities", "rows": [[3014276, "994c4126-69b3-409f-9c58-96a9dd60f1dc", "Q2", "HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC", 17966, "EMERGENT BIOSOLUTIONS", 2023, "second_quarter", "DIS", "Draft Departments of Labor, Health and Human Services, and Education, and related agencies' Appropriations Bill, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures, including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; State opioid response (SOR) grant funding proposals; Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - P.L. 116-22; H.R. 2670 - National Defense Authorization bill (NDAA), 2024 - provisions related to biological and chemical defense and access to Naloxone.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2023-07-19T11:10:22-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3014276"], "units": {}, "query_ms": 0.30414899811148643, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}